Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Oct;12(Suppl 2):S235-S247.
doi: 10.21037/jtd-cus-2020-007.

Respiratory failure and sleep-disordered breathing in late-onset Pompe disease: a narrative review

Neeraj Mukesh Shah  1   2   3 , Lakshya Sharma  1   4 , Santhosh Ganeshamoorthy  1   4 , Georgios Kaltsakas  1   2   3
Affiliations
Review

Respiratory failure and sleep-disordered breathing in late-onset Pompe disease: a narrative review

Neeraj Mukesh Shah et al. J Thorac Dis. 2020 Oct.

Abstract

Late-onset Pompe disease (LOPD) is a rare autosomal recessive glycogen storage disease that results in accumulation of glycogen in muscle cells causing muscular weakness. It causes a progressive proximal myopathy, accompanied by respiratory muscle weakness, which can lead to ventilatory failure. In untreated LOPD, the most common cause of death is respiratory failure. Patients suffering from respiratory compromise may present with symptoms of sleep-disordered breathing (SDB) before overt signs of respiratory failure. Diaphragm weakness leads to nocturnal hypoventilation, which can result in sleep disruption. Both subjective and objective sleep quality can be impaired with associated excessive daytime sleepiness (EDS). Health-related quality of life worsens as sleep disturbance increases. The mainstay of treatment for SDB and respiratory failure in LOPD is non-invasive ventilation (NIV), which aims to ensure adequate ventilation, particularly during sleep, and prevent acute hypercapnic failure. These patients are at risk of acute deterioration due to lower respiratory tract infections; effective secretion clearance and vaccination against common pathogens is an important facet of care. Whilst disease-modifying enzyme replacement therapy (ERT) delays progression of locomotor dysfunction and prolongs life, its effect on respiratory function and SDB remains unclear. There are no data demonstrating the impact of ERT on sleep quality or SDB.

Keywords: Pompe disease; glycogen storage disease type II (GSDII); non-invasive ventilation (NIV); respiratory muscle function; sleep-disordered breathing (SDB); ventilatory failure.

PubMed Disclaimer

Conflict of interest statement

Conflicts of Interest: All authors have completed the ICMJE uniform disclosure form (available at http://dx.doi.org/10.21037/jtd-cus-2020-007). The series “5th Clinical Update Sleep” was commissioned by the editorial office without any funding or sponsorship. The authors have no conflicts of interest to declare.

Figures

Figure 1
Figure 1
Cellular processing of glycogen and the role of acid maltase in the conversion of glycogen to intracellular glucose.
Figure 2
Figure 2
The effect of pathophysiological changes of LOPD on load-capacity-drive and their contribution to the development of hypoventilation. LOPD, late-onset Pompe disease.
Figure 3
Figure 3
Components of the multidisciplinary team caring for a patient with LOPD and the roles they perform. LOPD, late-onset Pompe disease.
See this image and copyright information in PMC

References

    1. Kishnani PS, Hwu WL, Mandel H, et al. A retrospective, multinational, multicenter study on the natural history of infantile-onset Pompe disease. J Pediatr 2006;148:671-6. 10.1016/j.jpeds.2005.11.033 - DOI - PubMed
    1. van den Hout HM, Hop W, van Diggelen OP, et al. The natural course of infantile Pompe's disease: 20 original cases compared with 133 cases from the literature. Pediatrics 2003;112:332-40. 10.1542/peds.112.2.332 - DOI - PubMed
    1. Toscano A, Rodolico C, Musumeci O. Multisystem late onset Pompe disease (LOPD): an update on clinical aspects. Ann Transl Med 2019;7:284. 10.21037/atm.2019.07.24 - DOI - PMC - PubMed
    1. Soliman OI, van der Beek NA, van Doorn PA, et al. Cardiac involvement in adults with Pompe disease. J Intern Med 2008;264:333-9. 10.1111/j.1365-2796.2008.01966.x - DOI - PubMed
    1. van der Beek NA, Soliman OI, van Capelle CI, et al. Cardiac evaluation in children and adults with Pompe disease sharing the common c.-32-13T>G genotype rarely reveals abnormalities. J Neurol Sci 2008;275:46-50. 10.1016/j.jns.2008.07.013 - DOI - PubMed